Has Mark McLaughlin received payments from drug or device companies?

Yes. Drug and device makers reported $6,426 in general payments to Mark McLaughlin across 407 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark McLaughlin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark McLaughlin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark McLaughlin

Family Medicine · Mt Pleasant, SCNPI 1972552438

Payments from drug & device makers

$6,426in general payments, 2019–2025

Across 407 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$959
Amgen$560
Amarin Pharma, Inc.$557
Boehringer Ingelheim$525
Pfizer$486
Merck$448
plus $3K from 35 others

What the payments were for

Food & beverage$6,422100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	45	$959
Amgen	40	$560
Amarin Pharma, Inc.	34	$557
Boehringer Ingelheim	34	$525
Pfizer	34	$486
Merck	36	$448
AbbVie(2 entities)	30	$387
Novo Nordisk	21	$344
Johnson & Johnson	21	$294
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$159
Novartis	10	$154
Takeda Pharmaceuticals U.S.A., Inc.	8	$148
Lilly USA, LLC	9	$133
Esperion Therapeutics, Inc.	8	$124
Daiichi Sankyo Inc.	8	$122
Eisai Inc.	8	$115
GSK	6	$108
Biohaven Pharmaceuticals, Inc.	5	$103
Sanofi-aventis U.S. LLC	5	$79
Genentech USA, Inc.	5	$77
Biohaven Pharmaceutical Holding Company Ltd.	3	$68
Abbott	3	$61
Hikma Pharmaceuticals USA	3	$49
Medicure Pharma Inc.	1	$41
Astellas Pharma US Inc	2	$39
Bayer	2	$34
Biogen	2	$33
Shire North American Group Inc	2	$27
Intuity Medical Inc	1	$26
Paratek Pharmaceuticals, Inc.	1	$22
Circassia Inc.	1	$17
E.r. Squibb & Sons, L.L.C.	1	$16
Almatica Pharma LLC	1	$15
Arbor Pharmaceuticals, Inc.	1	$13
Adlon Therapeutics L.p.	1	$13
Alnylam Pharmaceuticals Inc.	1	$13
Teva Pharmaceuticals USA, Inc.	1	$13
Boston Scientific	1	$13
Evofem Biosciences, Inc.	1	$12
Ultragenyx Pharmaceutical Inc.	1	$12
Neuronetics, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,426 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Other family medicine in Mt Pleasant

Richard WilkesMt Pleasant$216K
Valerie ScottMt Pleasant$23K
Cayce TangemanGoose Creek$8.4M
Jeremy AckermannMoncks Corner$7.6M
Kelly MoralesNorth Charleston$6.5M
William ByarsGreer$4.8M
James FranklinGreenville$3.5M
Stephen GrubbLittle River$3.4M
Jeffrey HarrisGreenville$3.4M
Shannon ConradN Charleston$3.3M

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →